15
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Factors in Human Pancreatic Cancer, with Special Reference to Quantitative Histology

, , , , , , , & show all
Pages 483-490 | Received 28 Aug 1990, Accepted 29 Nov 1990, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

S. Linder, A.-R. Weger, J. Lindholm, H. Jul M. Blåsjö, P. Sundelin & A. Von Rosen. (1994) Morphometric Characteristics in Adenocarcinoma of the Pancreas and Chronic Pancreatitis. Scandinavian Journal of Gastroenterology 29:8, pages 764-768.
Read now
P. K. Lipponen, M. J. Eskelinen, K. Jauhiainen, E. Harju, R. Terho & H. Haapasalo. (1993) Prognostic Factors in Nodular Transitional Cell Bladder Tumours. Scandinavian Journal of Urology and Nephrology 27:2, pages 205-210.
Read now
M. Eskelinen, P. Lipponen, S. Marin, H. Haapasalo, K. Mäkinen, J. Puittinen, E. Alhava & S. Nordling. (1992) DNA Ploidy, S-Phase Fraction, and G2 Fraction as Prognostic Determinants in Human Pancreatic Cancer. Scandinavian Journal of Gastroenterology 27:1, pages 39-43.
Read now

Articles from other publishers (18)

Huaiqian Dou, Guirong Sun & Lijuan Zhang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A 229 239 .
Mark M. Aloysius, Shivanthi J. De Silva Hewavisenthi, Timothy E. Bates, Brian J. Rowlands, Dileep N. Lobo & Abed M. Zaitoun. (2010) Predictive Value of Tumor Proliferative Indices in Periampullary Cancers: Ki-67, Mitotic Activity Index (MI) and Volume Corrected Mitotic Index (M/V) Using Tissue Microarrays. World Journal of Surgery 34:9, pages 2115-2121.
Crossref
Fumihiko Ishikawa, Norio Saito, Keiji Koda, Nobuhiro Takiguchi, Kenji Oda, Masato Suzuki, Masao Nunomura, Hiromi Sarashina & Masaru Miyazaki. (2002) Nuclear morphometric analysis of T2 lesions of the rectum—a simple, reproducible method for predicting malignancy potential. The American Journal of Surgery 183:6, pages 686-691.
Crossref
Stefan Linder, Margareta Blåsjö, Anette von Rosen, Concepcion Parrado, Ursula G. Falkmer & Sture Falkmer. (2001) Pattern of Distribution and Prognostic Value of Angiogenesis in Pancreatic Duct Carcinoma: A Semiquantitative Immunohistochemical Study of 45 Patients. Pancreas 22:3, pages 240-247.
Crossref
Joaquín Cubiella, Antoni Castells, Constantino Fondevila, Miquel Sans, Luís Sabater, Salvador Navarro & Laureano Fernández-Cruz. (1999) Prognostic Factors in Nonresectable Pancreatic Adenocarcinoma: A Rationale to Design Therapeutic Trials. American Journal of Gastroenterology 94:5, pages 1271-1278.
Crossref
Carolyn C. Compton & Sean J. Mulvihill. (1997) Prognostic Factors in Pancreatic Carcinoma. Surgical Oncology Clinics of North America 6:3, pages 533-554.
Crossref
T. J. O. Liukkonen, P. K. Lipponen, M. Helle, H. K. Haapasalo, S. Nordling & P. Rajala. (1996) Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in suerficial bladder cancer. Urological Research 24:1, pages 61-66.
Crossref
Stefan Linder, Johan Lindholm, Ursula Falkmer, Margareta Blåsjö, Pär Sundelin & Anette von Rosen. (1995) Combined use of nuclear morphometry and DNA ploidy as prognostic indicators in nonresectable adenocarcinoma of the pancreas. International Journal of Pancreatology 18:3, pages 241-248.
Crossref
Pier Cristoforo Giulianotti, Ugo Boggi, Gino Fornaciari, Joseph Bruno, Giuseppe Rossi, Demostene Giardino, Giulio Di Candio & Franco Mosca. (1995) Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. International Journal of Pancreatology 17:3, pages 279-289.
Crossref
M. Yamamoto, Y. Saitoh & P. Hermanek. 1995. Prognostic Factors in Cancer. Prognostic Factors in Cancer 105 117 .
Bertil Johansson, Georgia Bardi, Nikos Pandis, Ludmila Gorunova, Pia Lena Bäckman, Nils Mandahl, Sigmund Dawiskiba, åke Andrén‐Sandberg, Sverre Heim & Felix Mitelman. (2006) Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumour grade. International Journal of Cancer 58:1, pages 8-13.
Crossref
Matti Eskelinen, Leena Aittooja, Outi Hall, Pertti Lipponen & Kari Syrjänen. (2006) The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma. International Journal of Cancer 55:4, pages 547-554.
Crossref
P. K. LIPPONEN, M. J. ESKELINEN, K. JAUHIAINEN, R. TERHO & S. NORDLING. (2008) Proliferation Indices as Independent Prognostic Factors in Papillary Ta‐T1 Transitional Cell Bladder Tumours . British Journal of Urology 72:4, pages 451-457.
Crossref
P. K. Lipponen, M. J. Eskelinen, K. Jauhiainen, E. Harju, P. Terho & H. Haapasalo. (1992) Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index. Journal of Cancer Research and Clinical Oncology 118:8, pages 615-620.
Crossref
P. K. Lipponen, M. J. Eskelinen, K. Jauhiainen, E. Harju, R. Terho & H. Haapasalo. (2006) Independent clinical, histological and quantitative prognostic factors in transitional‐cell bladder tumours, with special reference to mitotic frequency. International Journal of Cancer 51:3, pages 396-403.
Crossref
P.K. Lipponen, M.J. Eskelinen, K. Jauhiainen, R. Terho & S. Nordling. (1992) Independent prognostic factors in T2/T3 transitional cell bladder tumours with special reference to histoquantitative methods. Surgical Oncology 1:2, pages 135-143.
Crossref
S. Aaltomaa, P. Lipponen, M. Eskelinen, V. -M. Kosma, S. Marin, E. Alhava & K. Syrj�nen. (1992) Mitotic indexes as prognostic predictors in female breast cancer. Journal of Cancer Research and Clinical Oncology 118:1, pages 75-81.
Crossref
S. Aaltomaa, P. Lipponen, M. Eskelinen, V.-M. Kosma, S. Marin, E. Alhava & K. Syrjänen. (1991) Prognostic factors in axillary lymph node-negative (pN−) breast carcinomas. European Journal of Cancer and Clinical Oncology 27:12, pages 1555-1559.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.